An update of the Medicines Waiting List report has just been released. The Medicines Waiting List shows how long patients have been waiting for medicines that have been positively recommended by PHARMAC’s clinical expert committee PTAC but are not yet funded by PHARMAC. This report is the fifth of it’s type and also compares the current waiting...Continue Reading

The impact of age, ethnicity and socio-economic deprivation in the era of novel anti-myeloma agents is unclear. Using linked national data from New Zealand, we evaluated the incidence, prevalence and overall survival (OS) of individuals who were diagnosed with myeloma between 2004 and 2016. The crude incidence rate increased from 5.42 to 8.47/100 000 and...Continue Reading